Open Access

Ginkgo biloba extract protects human neuroblastoma SH‑SY5Y cells against oxidative glutamate toxicity by activating redoxosome‑p66Shc

  • Authors:
    • Ke Wang
    • Jing Ni
    • Xue Zhu
    • Ling Zhu
    • Yue Li
    • Fanfan Zhou
  • View Affiliations

  • Published online on: July 5, 2021     https://doi.org/10.3892/etm.2021.10383
  • Article Number: 951
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ginkgo biloba extract (GBE), a traditional Chinese herbal medicine component, is widely used to alleviate symptoms of neurodegenerative diseases. It has been confirmed that GBE exerts its pharmacological effect mainly due to its antioxidant activity; however, the molecular mechanism responsible for this effect remains unclear. The aim of the present study was to investigate the detailed mechanism of GBE, the main component of Gingko biloba dropping medicine, against oxidative glutamate toxicity in human neuroblastoma SH‑SY5Y cells. The SH‑SY5Y cells were untreated or pretreated with GBE followed by glutamate stimulation. Cell viability was assessed using an MTT assay. In addition, oxidative stress indexes, including intracellular ROS generation and NADPH oxidase and caspase activity, were also measured. The protein expression of key signaling factors involved in the redoxosome‑p66Shc pathway was evaluated to elucidate the neuroprotective effect of GBE. The results showed that GBE treatment significantly attenuated the glutamate‑induced cytotoxicity in SH‑SY5Y cells by suppressing oxidative stress. A mechanical study revealed that redoxosome‑p66Shc activation was associated with glutamate‑induced cytotoxicity, which caused mitochondrial dysfunction and cell death. Interestingly, GBE treatment attenuated the activation of redoxosome‑p66Shc in a dose‑dependent manner, which suggested that the protective effect of GBE on SH‑SY5Y cells against oxidative glutamate toxicity may be mediated by the modulation of redoxosome‑p66Shc signaling. The current findings contribute to a better understanding of the therapeutic effect of GBE and indicate that redoxosome‑p66Shc signaling might be a novel therapeutic target in the prevention and/or treatment of neurodegenerative diseases.
View Figures
View References

Related Articles

Journal Cover

September-2021
Volume 22 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang K, Ni J, Zhu X, Zhu L, Li Y and Zhou F: <em>Ginkgo biloba</em> extract protects human neuroblastoma SH‑SY5Y cells against oxidative glutamate toxicity by activating redoxosome‑p66Shc. Exp Ther Med 22: 951, 2021.
APA
Wang, K., Ni, J., Zhu, X., Zhu, L., Li, Y., & Zhou, F. (2021). <em>Ginkgo biloba</em> extract protects human neuroblastoma SH‑SY5Y cells against oxidative glutamate toxicity by activating redoxosome‑p66Shc. Experimental and Therapeutic Medicine, 22, 951. https://doi.org/10.3892/etm.2021.10383
MLA
Wang, K., Ni, J., Zhu, X., Zhu, L., Li, Y., Zhou, F."<em>Ginkgo biloba</em> extract protects human neuroblastoma SH‑SY5Y cells against oxidative glutamate toxicity by activating redoxosome‑p66Shc". Experimental and Therapeutic Medicine 22.3 (2021): 951.
Chicago
Wang, K., Ni, J., Zhu, X., Zhu, L., Li, Y., Zhou, F."<em>Ginkgo biloba</em> extract protects human neuroblastoma SH‑SY5Y cells against oxidative glutamate toxicity by activating redoxosome‑p66Shc". Experimental and Therapeutic Medicine 22, no. 3 (2021): 951. https://doi.org/10.3892/etm.2021.10383